CHARGE syndrome by Blake, Kim D & Prasad, Chitra
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
Orphanet Journal of Rare Diseases
Open Access Review
CHARGE syndrome
Kim D Blake*1 and Chitra Prasad2
Address: 1Department of Pediatrics, IWK Health Centre, Dalhousie University, Canada and 2Department of Pediatrics, London Health Sciences 
Center, University of Western Ontario, Canada
Email: Kim D Blake* - kblake@dal.ca; Chitra Prasad - Chitra.Prasad@lhsc.on.ca
* Corresponding author    
Abstract
CHARGE syndrome was initially defined as a non-random association of anomalies (Coloboma,
Heart defect, Atresia choanae, Retarded growth and development, Genital hypoplasia, Ear
anomalies/deafness). In 1998, an expert group defined the major (the classical 4C's: Choanal atresia,
Coloboma, Characteristic ears and Cranial nerve anomalies) and minor criteria of CHARGE
syndrome. Individuals with all four major characteristics or three major and three minor
characteristics are highly likely to have CHARGE syndrome. However, there have been individuals
genetically identified with CHARGE syndrome without the classical choanal atresia and coloboma.
The reported incidence of CHARGE syndrome ranges from 0.1–1.2/10,000 and depends on
professional recognition. Coloboma mainly affects the retina. Major and minor congenital heart
defects (the commonest cyanotic heart defect is tetralogy of Fallot) occur in 75–80% of patients.
Choanal atresia may be membranous or bony; bilateral or unilateral. Mental retardation is variable
with intelligence quotients (IQ) ranging from normal to profound retardation. Under-development
of the external genitalia is a common finding in males but it is less apparent in females. Ear
abnormalities include a classical finding of unusually shaped ears and hearing loss (conductive and/
or nerve deafness that ranges from mild to severe deafness). Multiple cranial nerve dysfunctions
are common. A behavioral phenotype for CHARGE syndrome is emerging. Mutations in the CHD7
gene (member of the chromodomain helicase DNA protein family) are detected in over 75% of
patients with CHARGE syndrome. Children with CHARGE syndrome require intensive medical
management as well as numerous surgical interventions. They also need multidisciplinary follow up.
Some of the hidden issues of CHARGE syndrome are often forgotten, one being the feeding
adaptation of these children, which needs an early aggressive approach from a feeding team. As the
child develops, challenging behaviors become more common and require adaptation of educational
and therapeutic services, including behavioral and pharmacological interventions.
Disease name/synonyms
CHARGE (Coloboma, Heart defect, Atresia choanae,





The CHARGE association was first described in 1979 by
Hall et al., in 17 children with multiple congenital anom-
alies who were ascertained by choanal atresia [1]. In the
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same year, Hittner reported this syndrome in 10 children
with ocular colobomas and multiple congenital anoma-
lies [2], hence the syndrome is also called Hall-Hittner
syndrome [3]. Pagon et al., in 1981 first coined the acro-
nym CHARGE association [4] (Coloboma, Heart defect,
Atresia choanae, Retarded growth and development, Gen-
ital hypoplasia, Ear anomalies/deafness) as a non-ran-
dom association of anomalies occurring together more
frequently than one would expect on the basis of chance.
The original diagnostic criteria required the presence of
four out of six of the CHARGE characteristics. Over the
past 15 years the specificity of this pattern of malforma-
tions has reached the level that many clinicians now con-
sider it to be a recognizable CHARGE syndrome [1].
Diagnostic criteria
With increasing experience, it has become clear that the
CHARGE association criteria originally proposed by
Pagon  et al. [4], needed further refinement. An expert
group of geneticists and developmental pediatricians
defined the major and minor criteria of CHARGE syn-
drome in 1998 [5]. Major criteria are those findings that
occur commonly in CHARGE syndrome but are relatively
rare in other conditions. The minor criteria occur less fre-
quently or are less specific to CHARGE syndrome (Table
1, first two columns).
A diagnosis of CHARGE syndrome should be considered
in any neonate with coloboma, choanal atresia, asymmet-
ric facial palsy or classical CHARGE ears in combination
with other specific congenital anomalies [6] (Table 1).
Individuals with all four major characteristics (the classi-
cal 4C's: Choanal atresia, Coloboma, Characteristic ears
and Cranial nerve anomalies) or three major and three
minor characteristics are highly likely to have CHARGE
syndrome [5]. In some children, the presence of a cleft lip
and palate can substitute for choanal atresia, since the two
defects rarely occur together. Some of the CHARGE fea-
tures are difficult to detect in the neonatal period; there-
fore, the diagnosis needs to be considered in any infant
with one or two major criteria and several minor charac-
teristics. CHARGE syndrome has also occurred in an indi-
vidual with no coloboma or choanal atresia [7].
Epidemiology
The true incidence of CHARGE syndrome is not known,
with estimates ranging from 0.1–1.2/10,000 live births. A
national surveillance study of CHARGE syndrome
patients has been conducted through the Canadian Pedi-
atric Surveillance Programme (CPSP) from September
2001 – 2004 [8]. The highest incidence of CHARGE syn-
drome in Canada was estimated at 1:8,500 live births in
provinces with a research interest in CHARGE syndrome
[9]. The true incidence of CHARGE syndrome reported
internationally may therefore be underestimated [10].
Clinical description
CHARGE syndrome includes the following features:
Coloboma
This feature may be unilateral or bilateral and may affect
only the iris or extend to involve the retina, or only the ret-
ina. Vision may be normal or impaired. The eye abnor-
malities range from iris coloboma without visual
impairment to microphthalmos and anophthalmos. Reti-
nal coloboma is more prevalent than iris coloboma and
can affect the optic nerve. Eye malformations have been
reported in as many as 80% of patients with CHARGE syn-
drome, with retinal involvement being the most common
[11]. External inspection is not sufficient and testing for
functional vision is important but challenging especially
in CHARGE individuals with extensive bilateral chorioret-
inal coloboma involving the optic nerve [12].
Heart defect
Congenital heart defects occur in 75–80% of patients with
CHARGE syndrome. The most common major heart
defect is tetralogy of Fallot (33%). Other frequent anom-
alies are patent ductus arteriosus, double outlet right ven-
tricle with atrioventricular canal, ventricular septal defect
and atrial septal defect with or without cleft mitral valve.
Vascular rings and more complex heart defects need to be
anticipated [13-16].
Atresia choanae
Choanal atresia is a narrowing or a blockage of the pas-
sages between the nasal cavity and the naso-pharynx. It
represents a primary feature with a high index of suspicion
for CHARGE syndrome and it should focus attention on
other organ systems such as the eye and heart. Choanal
atresia may be membranous or bony; bilateral or unilat-
eral. Bilateral posterior choanal atresia (BPCA) was shown
to be associated with increased neonatal mortality, espe-
cially if associated with major cardiac malformations +\-
tracheoesophageal atresia [13]. However, the Canadian
epidemiological study data suggests that an individual
from this population with a more severe clinical presenta-
tion of CHARGE features generally survive [9]. Polyhy-
dramnios in pregnancy is seen commonly in individuals
with bilateral posterior choanal atresia, and may also be
present without BPCA, probably due to an insufficient
swallowing mechanism. Chronic middle ear infections
and deafness can be associated complications of choanal
atresia [17].
Retardation of growth and development
Growth and developmental retardation become more
obvious as the child matures. At birth, children with
CHARGE syndrome usually have normal weights and
lengths [18]. When growth deceleration is due to cardiac
and respiratory problems, there may be catch up growth,Orphanet Journal of Rare Diseases 2006, 1:34 http://www.OJRD.com/content/1/1/34
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and normal height can be obtained [19]. However, the
influence of feeding problems on growth in infancy
should not be underestimated. Early and continued inter-
vention for feeding difficulties is vitally important [20];
occasionally there is growth hormone deficiency. The
majority of school-aged children with CHARGE syn-
drome are below the third percentile for physical growth
norms [18]; feeding with solids and lumpy foods, and risk
of aspiration may still exist.
Mental retardation is variable with intelligence quotients
(IQ) ranging from near-normal to profound retardation.
Behavioral issues and an autism-like spectrum disorder
are now being recognized as features of the syndrome
[21,22].
The adult patient population is at risk of obesity (personal
communication and observation by Dr. Kim Blake).
Growth in height can occur in adults with CHARGE syn-
drome well into their 20's [19].
Genitourinary problems
Under-development of the external genitalia is a common
finding in males but it is more difficult to recognize in
Table 1: Diagnostic criteria for CHARGE syndrome
Features of CHARGE syndrome Later childhood/adolescent issues*
Major 4C's **
Ocular coloboma Coloboma -of iris, retina, choroid, disc; 
microphthalmia
Photophobia; retinal detachment Corneal abrasions
Choanal atresia/stenosis Choanal atresia (or Cleft palate) – unilateral/bilateral, 
membranous/bony, stenosis/atresia
Facial growth problems, recurrent closure and 
resurgeries, unilateral nasal discharge
Cranial nerve anomalies Cranial nerve dysfunction – Olfactory tract anomalies 
– Facial palsy (unilateral or bilateral), Sensorineural 
deafness, Velopharyngeal incoordination – swallowing 
problems
Feeding/swallowing problems; gastroesophageal reflux; 
hiatus hernia
Characteristic ear anomalies Characteristic ear abnormalities – External ear (lop or 
cup shaped),, Middle ear (ossicular malformations, 
chronic serous otitis), mixed deafness, semicircular 
canal +/-cochlear defects
Progressive hearing loss; chronic middle ear infections; 
vestibular problems affecting balance and/or motor 
skills.
Minor
Cardiovascular malformations Cardiovascular malformations – All types: especially 
conotruncal defects (e.g. Tetralogy of Fallot), AV canal 
defects, and aortic arch anomalies
Arrhythmias; angina; further cardiac surgeries
Genital hypoplasia Genital hypoplasia – Males: micropenis, 
cryptorchidism; Females: hypoplastic labia, Both: 
Delayed incomplete pubertal development
Pubertal delay, hormone replacement; fertility 
(unsure); hypogonadotrophic hypogonadism, 
osteoporosis
Cleft lip/palate Orofacial cleft – Cleft lip and/or palate Cosmetic concerns; self-image
Tracheoesophageal fistula Tracheoesophageal fistula – Tracheoesophageal 
defects of all types
Reflux esophagitis; feeding/swallowing problems
Distinctive CHARGE facies Characteristic face – sloping forehead, flattened tip of 
nose
Cosmetic concerns; self-image
Growth deficiency Growth deficiencies – Short stature Borderline growth 
hormone (GH) stimulation tests
Growth hormone (GH) replacement Obesity
Developmental delay Developmental delay – Delayed motor milestones, 
language delay, mental retardation
Educational, behavioural, social adjustment issues; 
Autistic-like problems; Obsessive compulsive 
disorders; Attention Deficit Hyperactivity Disorder 
(ADHD)
Occasional***
Renal anomalies Duplex system, Vesicoureteric reflux Renal failure
Spinal anomalies Scoliosis; Osteoporosis Scoliosis
Hand anomalies Fifth finger clinodactyly, camptodactyly and cutaneous 
syndactyly
Fine motor problems; cosmetic concern
Neck/shoulder anomalies Sloping, Sprengel's deformity, kyphosis Self-image concern
* A premature aging phenomenom may exist in the older population, however, further research studies are required.
** Absent olfactory pathways and absent/abnormal semicircular canals are cardinal radiological findings for CHARGE syndrome.
***The occasional findings are more prevalent than originally predicted [8–9]Orphanet Journal of Rare Diseases 2006, 1:34 http://www.OJRD.com/content/1/1/34
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females. Microphallus, penile agenesis, hypospadias,
chordee, cryptorchidism, bifid scrotum, atresia of uterus,
cervix and vagina, hypoplastic labia and clitoris are
reported genital anomalies in this syndrome. Reported
renal anomalies include solitary kidney, hydronephrosis,
renal hypoplasia, duplex kidneys and vesicoureteral
reflux. Hypogonadotrophic hypogonadism has been
reported and is associated with delays in puberty or
pubertal arrest [23,24].
Ear, olfactory and other cranial nerve anomalies
Ear abnormalities include a classical finding of unusually
shaped ears [6]. Lack of cartilage to the outer ear with defi-
cient 7th nerve innervation to intrinsic ear muscles pro-
duces a prominent lop- or cup-shaped ear with a
hypoplastic lobule (Figure 1). Hearing loss, conductive
and/or nerve deafness, ranges from mild to severe. Ear
anomalies were reported in 80–100% of cases in different
series [5,7,15,25]. Facial nerve palsies were noted to be a
reliable predictor of sensorineural hearing loss. The char-
acteristic abnormalities demonstrated by temporal bone
computerized tomography (CT) or magnetic resonance
imaging (MRI) scan include hypoplastic incus, decreased
numbers of turns to the cochlea (Mondini defect), and, in
particular, absent semicircular canals. These distinctive
radiological findings are classical for CHARGE syndrome
and can aid diagnosis in a suspected case [26]. For this rea-
son, a neonatal CT scan to look at the choanae and tem-
poral bones can be extremely useful.
The major diagnostic criteria for CHARGE syndrome [5]
include cranial nerve (CN) anomalies, which are usually
asymmetric. Cranial nerve dysfunctions include: CN I
(anosmia). Absence or anomalies of the olfactory bulb are
highly indicative of CHARGE syndrome [27] CN VII
(facial palsy); CN IX/X/XI (swallowing problems, gastro-
esophal reflux, and velopharyngeal aspiration); and CN
VIII (sensorineural hearing loss) [14,28]. CN V and CN II
may also be involved [29].
Behavioral phenotype
There are many challenging behaviors that are expressed
in individuals with CHARGE syndrome. Multiple studies
[21] from four different countries, using a variety of test
instruments, came up with similar themes and similar
behavioral patterns in children with CHARGE syndrome
[21,22,30-34]. Children with CHARGE syndrome have
relatively low adaptive behavior skills and motor impair-
ments being particularly significant, with symptoms of
autistic spectrum disorder (ASD). The behavior they dis-
play is often very adaptive to their environment and to
their own disabilities. These behaviors may be partially
related to problems with arousal and self-regulation.
Taken together, the articles in this series reveal the emer-
gence of behavioral phenotypes that are perhaps specific
to CHARGE syndrome [21]. Data are emerging about the
unique behavioral phenotype of CHARGE syndrome
compared to other genetic syndromes such as Down syn-
drome, Prader-Willi syndrome and Williams syndrome
[30] and the Autism spectrum.
Etiology
There is a crucial stage of embryogenesis, when failure to
rupture the primitive bucconasal membrane (35th to 38th
day) brings about choanal atresia. Conotruncal cardiac
defects can result from aberrations in cephalic neural crest
cell migration during the 4th and 5th weeks after concep-
tion. The cochlear duct begins to develop around the 36th
day, and the eyes develop between days 34 and 44 days
post-conception, which is also the time during which
many cranial nerves are developing. All the malforma-
tions in CHARGE syndrome occur early during the first tri-
mester. In situ hybridization analysis of the CHD7 gene
during early human development showed a good correla-
tion between CHD7 expression patterns and the develop-
mental anomalies observed in CHARGE syndrome [35].
CHARGE syndrome: unusually shaped ears showing cochlear  transplant Figure 1
CHARGE syndrome: unusually shaped ears showing cochlear 
transplant.Orphanet Journal of Rare Diseases 2006, 1:34 http://www.OJRD.com/content/1/1/34
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Mutations in a member of the chromodomain gene family 
– CHD7
A team from Radboud University Nijmegen, The Nether-
lands, identified (by array-based comparative genomic
hybridization) a small overlapping microdeletion at chro-
mosome 8q12 in two patients with CHARGE syndrome.
Within this region the candidate CHD7 gene was identi-
fied and sequenced in 17 patients. Initially, 10 patients
had an identified mutation [36]. After improvement of
the sequencing procedure, a mutation was found in 16 of
the 17 original patients [7]. CHD7 is a large gene contain-
ing 38 exons. Most mutations found are stop or frame
shift mutations resulting in truncation of the CHD7 pro-
tein. So far, no mutation hot spots have been found and
mutations are scattered throughout the gene. In two large
independent series of patients with CHARGE syndrome,
mutations were found in 69 out of 107 (64%) CHARGE
patients [7] and 64 of 110 (58%) CHARGE patients [25].
Both studies required full-gene sequencing of this large
gene. Most mutations are found in patients who fulfill the
clinical criteria for CHARGE syndrome, especially when
they have absence of the semicircular canals and olfactory
bulbs. The CHARGE phenotype may be related to the
actual mutations within the CHD7 gene, as may the later
onset features and behavioral phenotype. van Raven-
swaaij found that a 26 year old woman with various
CHARGE features and normal intelligence tested positive
for the CHD7 mutation. Johnson [37] have also associ-
ated CHD7 mutations with CHARGE association by map-
ping a balanced chromosome translocation in affected
monozygotic twins, thus confirming the earlier findings
of the Dutch team. It is interesting to note that in the few
reported studies of monozygotic twins with mutations in
CHD7, there has been discordant expression of the syn-




￿ Karyotype to confirm the integrity of chromosome num-
bers 22, 14, and 9.
￿ Fluorescent in situ hybridization (FISH) to exclude
22q11 deletion.
￿ CHD7 gene mutation testing is now becoming available
on a clinical basis. Molecular technologies are preferred
because detection of deletions using FISH for the CHD7
gene is rare [36,38].
￿ Comparative genomic hybridization should be consid-
ered in patients with CHARGE syndrome and normal
CHD7 mutation analysis results.
Biochemical
Blood urea nitrogen, creatinine, electrolytes and calcium
should be measured to evaluate renal function and
exclude hypocalcemia. If hypocalcemia is found, T-cells
should be evaluated for signs of DiGeorge sequence.
Hormonal
￿ In cases of hypogenitalism, Luteinising Hormone
Releasing Hormone (LHRH) and Human Chorionic
Gonadotropin (HCG) tests should be performed to eval-
uate the pituitary gonadal axis (needs to be completed in
the first four months of life or at puberty). Growth hor-
mone (GH) stimulation levels should be investigated to
exclude deficiency of GH as a cause for growth retarda-
tion.
￿ Frequent measurements of growth are required, prepu-
bertally a left hand X-ray for bone age, followed by screen-
ing for hypogonadotrophic hypogonadism in early
puberty.
Cardiac
Echocardiogram to should be conducted to identify and/
or exclude congenital cardiac defects. Holter monitoring
should be used to detect rhythm abnormalities.
Hearing
Audiometry and auditory brainstem response should be
examined to document the type and severity of conduc-
tive and sensorineural hearing loss (often needs repeating,
and different audiological tests may be performed as the
child matures).
Vision
Visual analysis, and electroretinogram and functional
vision testing should be conducted to identify and docu-
ment the severity of visual loss [11,12].
Radiological
Skeletal survey should be carried out to exclude skeletal
anomalies, particularly those of the cervical spine. Scolio-
sis is more prevalent than previously reported [41].
Frequent feeding assessments (depending on the severity
of the feeding issues), including combinations of barium
swallow, reflux scan, pH monitoring with a pediatric gas-
troenterologist and feeding team should be conducted to
diagnose swallowing dysfunction, esophageal dysmotil-
ity, and frequent severe gastroesophageal reflux (GER)
and tracheal aspiration [13,20].
Head CT and/or MRI scans, including imaging of the tem-
poral bones should be performed to exclude cerebral mal-
formation and defective formation of the ossicles of the
middle ear, cochlear and semicircular canals. DetailedOrphanet Journal of Rare Diseases 2006, 1:34 http://www.OJRD.com/content/1/1/34
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radiological visualization of the olfactory tracts and the
cranial nerves are desirable and require fine cuts. The
olfactory bulbs and tracts imaging may be pathogno-
monic for CHARGE syndrome [27].
Abdominal ultrasound and voiding cystourethrogram
should be carried out to exclude renal anomalies.
Radiological testing should include a DEXA scan for oste-
oporosis.
Differential diagnosis
Some characteristics of CHARGE syndrome overlap with
those of other conditions including: VACTERL associa-
tion, DiGeorge sequence [42], Velo-cardio-facial syn-
drome (VCFS), Cat Eye syndrome, retinoic acid
embryopathy, and PAX2 abnormalities (The PAX2 gene is
expressed in primitive cells of the kidney, ureter, eye, ear
and central nervous system). Furthermore, several differ-
ent structural chromosome abnormalities have been
reported in children with coloboma, choanal atresia, and/
or heart defects (some examples are: deletion 18q22.3-
qter, duplication 2q37.3-qter, deletion 3p25.1-pter, dele-
tion 22q11.1-qter, duplication 14q22-q24.3 and duplica-
tion 8q22-qter). Although still very rare, since the
discovery of the CHD7 gene mutation, several patients
with a submicroscopic deletion of 8q12 that includes the
CHD7 gene have been reported [42].
It is important to rule out a submicroscopic chromosomal
deletion of 22q11 with FISH analysis in all patients sus-
pected of CHARGE syndrome, especially those with
thymic hypoplasia and hypocalcemia. PAX2 abnormali-
ties can lead to renal problems and ocular coloboma but
few of the other features of CHARGE syndrome have been
observed in such children [43].
The syndrome with hypoplasia of the depressor anguli
oris muscle and cardiac defects also overlaps with both
CHARGE syndrome and Velo-cardio-facial syndrome
(VCFS). Retinoic acid embryopathy can produce ear, face,
heart and cranial nerve defects similar to CHARGE syn-
drome, however, brain malformations resulting from
retinoic acid embryopathy are usually much more severe.
Exposure to retinoic acid during critical periods of mor-
phogenesis has not been reported in children with
CHARGE syndrome.
Genetic counseling
Most cases of CHARGE syndrome are sporadic, occurring
in an otherwise normal family. The presence of CHARGE
syndrome like features should prompt a detailed evalua-
tion of the family members including parents. There are a
number of overlapping features with other conditions
such as DiGeorge syndrome, VATER, Oculo-auriculo-ver-
tebral syndrome thus all children/adults suspected with
CHARGE syndrome should have a formal genetics consul-
tation. The discovery of the CHD7 gene has led to the con-
clusion that most patients with CHARGE syndrome have
a de novo autosomal dominant mutation. The first parent-
to-child transmissions of CHD7  mutations, as well as
germ line mosaicism, have already been identified by the
Baylor group [25] and independently by the Vissers group
[36]. The documented empiric recurrence risk is around
2%. Two separate studies have revealed that advanced
paternal age is associated with sporadic cases of CHARGE
syndrome [44,45]. The recent gene discovery will impact
on genetic counseling and prenatal diagnosis issues.
Antenatal diagnosis
Most of the abnormalities associated with CHARGE syn-
drome are difficult to diagnose antenatally through ultra-
sound unless there is a high index of suspicion with the
presence of polyhydramnios. However, focused ultra-
sound for detection of external ear anomalies, choanal
atresia, semicircular canal agenesis and arhinencephaly
should lead to a higher prenatal defection rate. Moreover,
arhinencephaly and semicircular canal agenesis were two
constant features in fetuses with CHARGE syndrome and
CHD7 mutations [35]. If the CHD7 mutation is discov-
ered in the index CHARGE individual, then reliable pre-
natal diagnosis is possible by chorionic villus sampling or
amniocentesis.
Management
Children with CHARGE syndrome require intensive med-
ical management as well as numerous surgical interven-
tions. The most common neonatal emergencies in
CHARGE syndrome involve cyanosis due to bilateral pos-
terior choanal atresia and/or congenital heart defects, or
the less common presentation of tracheoesophageal fis-
tula. The primary foci of management should be airway
stabilization and circulatory support [5].
All patients suspected of having CHARGE syndrome
should have a cardiology consultation. If the infant has
restrictive pulmonary blood flow and is dependant on a
patent ductus arteriosus, the administration of prostag-
landin to maintain ductal patency may be life saving.
Some children require tracheostomy to manage chronic
airway problems and/or gastroesophageal reflux and aspi-
ration. Children with CHARGE syndrome require aggres-
sive medical management of their feeding difficulties,
often needing gastrostomy and jejunostomy feeding
tubes. Gastrooesophageal fundoplication may be
required for GER that does not respond to medical man-
agement. As intubation can be difficult in children with
CHARGE syndrome, a pediatric anesthesiologist or pedi-
atric otolaryngologist should be present for planned sur-
gical procedures.Orphanet Journal of Rare Diseases 2006, 1:34 http://www.OJRD.com/content/1/1/34
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Any infant suspected of having CHARGE syndrome
should have a complete eye examination by an ophthal-
mologist, with follow-up every three to six months there-
after, depending on the eye involvement. Photophobia is
often a significant problem that can be ameliorated with
tinted spectacles or by wearing a cap or visor with a dark
brim. In the presence of facial palsy, patients should avoid
corneal scarring by using artificial tears.
Hearing aids should be used as soon as hearing loss is doc-
umented. Frequent re-molding of the earpieces is neces-
sary as the ear canals can be initially very small and ear
cartilage may be insufficient to support a hearing aid.
Cochlear implantations have been successfully performed
in CHARGE syndrome patients. Children with CHARGE
syndrome who undergo cochlear implantation should be
allowed to continue with their sign language in parallel
with their expressive speech training [46]. Adapted educa-
tional and therapeutic services to deal with dual auditory
and visual sensory impairment should be proposed early
in the child's life [44-46]. However, this population is
unique with respect to their aberrant cranial nerve path-
ways and problems with expressive language.
In terms of endocrine issues, sex steroid therapy has been
used for penile growth and descent of testes in males with
CHARGE syndrome. The main use for testosterone is for
delayed and incomplete male puberty during adoles-
cence. Females often require hormone replacement at
puberty [23]. Sex hormone replacement is also indicated
for prevention of osteoporosis [24].
Unresolved questions
"Will early recognition and treatment of infants with
CHARGE syndrome improve their clinical and behavioral
well being?"
Clearly, early detection of the medical issues will have an
impact on the ultimate prognosis. Even so, the number of
medical issues in CHARGE syndrome make this popula-
tion very vulnerable to different clinical problems. Simi-
larly, the neurological outcome will depend on the
promptness of medical care and support services and any
underlying cranial anomalies.
"Is there a genotype/phenotype correlation between the
different CHARGE features and the different mutations in
the CHD7 gene?"
In a study of 110 patients [25] it has been shown that car-
diovascular malformations, coloboma and facial asym-
metry are common findings in CHARGE syndrome
caused by CHD7 mutation. Further studies of this kind
will increase understanding of the genotype/phenotype
correlation in CHARGE syndrome.
"Is there a distinct behavioral phenotype for CHARGE
syndrome and does this correlate with the different CHD7
mutations?"
We are seeing certain patterns of behavior such as obses-
sive compulsive and in the pervasive spectrum (autism
spectrum disorders).
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